Oncogenic HPV Detection via Segmented Probe Cocktails

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current HPV detection methods, such as the HPV Hybrid Capture II test and PCR-based assays, face challenges in selectively detecting oncogenic HPV types due to cross-reactions and non-specific binding, leading to reduced sensitivity and specificity, especially when multiple HPV types are targeted, which can result in false positives from non-oncogenic HPV types.

Innovation Solution

The development of novel nucleic acid constructs and methods that utilize selective hybridization, extension, and amplification techniques, including the use of chimeric sequences, degenerate nucleotides, and modified nucleotide analogues, to discriminately detect oncogenic HPV types while avoiding non-target sequences, allowing for simultaneous recognition of multiple oncogenic HPV types with reduced false positives from non-oncogenic types.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If a probe cocktail containing multiple individual HPV type probes is used to detect various oncogenic HPV types, then the sensitivity of detection for multiple HPV types is improved, but the specificity deteriorates due to cross-reactions with non-oncogenic HPV types

Engineering Contradiction:
Improvesensitivity of detectionVSAvoidspecificity
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The probe cocktail is segmented into multiple individual probe sets, each targeting specific oncogenic HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68). This segmentation allows selective detection of each type while maintaining overall cocktail functionality, reducing cross-reactivity compared to a single broad-specificity probe.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Each probe in the cocktail is designed with locally optimized specificity for its target HPV type sequence. The probes have unique sequence characteristics tailored to bind specifically to their intended oncogenic HPV type, allowing differential binding affinity that prevents cross-reaction with non-target types including low-risk HPV 6 and 11.

Inventive Principle:
Principle #3Local quality

2Measurement precision

If the concentration of each individual probe is increased to drive hybridization reactions, then the sensitivity for each HPV type is improved, but the complexity of the hybridization mixture increases leading to non-specific binding

Engineering Contradiction:
ImprovesensitivityVSAvoidcomplexity of hybridization mixture
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The hybridization conditions are optimized with specific parameters including temperature (42°C), salt concentration (6x SSC), and formamide content (50%) to enhance probe specificity. These parameter changes allow probes to discriminate between oncogenic and non-oncogenic HPV types based on subtle sequence differences, reducing non-specific binding even at lower probe concentrations.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The hybridization mixture is formulated as a composite system containing multiple probes at optimized concentrations, along with formamide and salt components that collectively enhance specificity. This composite formulation allows the mixture to function as a unified system with reduced cross-reactivity compared to simple probe suspensions.

Inventive Principle:
Principle #40Composite materials

3Measurement precision

If a broad spectrum of HPV types is targeted in the assay, then the sensitivity for detecting oncogenic HPV is improved, but false positive signals from non-oncogenic HPV types increase

Engineering Contradiction:
ImprovesensitivityVSAvoidfalse positive signals
Core Design Contradiction:
Measurement precisionVSObject-generated harmful factors

Solution Approach 1:

The probe design incorporates preliminary anti-action by including sequences that specifically recognize and bind to oncogenic HPV types while having reduced affinity for non-oncogenic types. The probes are pre-configured to differentiate between high-risk and low-risk HPV types through sequence complementarity, preventing false positive signals before they can occur.

Inventive Principle:
Principle #9Preliminary anti-action

Solution Approach 2:

The mechanical system of probe hybridization is replaced with a more selective molecular recognition system using probes with optimized sequence specificity. The molecular structure of the probes is designed to exploit subtle sequence differences between oncogenic and non-oncogenic HPV types, providing inherent discrimination without requiring additional mechanical separation steps.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the specificity and sensitivity of HPV detection, enabling the accurate identification of multiple oncogenic HPV types while minimizing false signals from non-oncogenic types, thereby improving the diagnostic and prognostic value of HPV testing.

Implementation Method 1

selective hybridization, extension, and amplification techniques

Methodology Applied
Scientific EffectHybridization:

Implementation Method 2

selective hybridization, extension, and amplification techniques

Methodology Applied
Scientific EffectExtension:

Implementation Method 3

selective hybridization, extension, and amplification techniques

Methodology Applied
Scientific EffectAmplification:

Data Source

PatentUS8124334B2Selective detection of oncogenic HPV
Publication Date: 2012.02.28 ENZO BIOCHEM INC
  • US8124334B2 patent drawing
  • US8124334B2 patent drawing
  • US8124334B2 patent drawing

AI summary

Compositions and methods for discriminately detecting the presence of a set of related genes from target organisms while avoiding detection of closely similar genes in non-target organisms. The present invention achieves this objective by a variety of novel nucleic acid constructs and methods. The nucleic acid constructs of the present invention are able to carry out this objective by virtue of the selected sequences of the compositions and by methods of use of such compositions.